Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study

In this video, vascular surgeon Nicolas Mouawad, MD, MPH, MBA, from McLaren Bay Region in Bay City, Michigan, highlights key findings from his presentation at ISET 2026 about the AVENTUS trial. This pivotal Investigational Device Exemption trial evaluated the safety and efficacy of the Aventus thrombectomy system (Inquis Medical) for the treatment of pulmonary embolism (PE). Dr Mouawad discusses how emerging thrombectomy technologies combined with autologous blood reinfusion may reshape the treatment landscape for PE, focusing on clinical outcomes, procedural efficiency, and patient safety.